Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 62.72% is 26% above its 5-year average of 49.78%, around the middle of its 5-year range (0.00%–89.74%).
As of the fiscal period ended Tuesday, March 31, 2026. 6.87% below its 12-month average of 67.35%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
62.72%
GROSS MARGIN AVG TTM
67.35%
GROSS MARGIN AVG 3Y
56.65%
GROSS MARGIN AVG 5Y
54.08%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-6.87%
CURRENT VS 3Y AVG
+10.71%
CURRENT VS 5Y AVG
+15.98%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
58.51%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+7.20%
vs the sector median at left
Market Cap
$6.75B
Gross Margin
67.64%
TTM Avg
76.65%
3Y Avg
78.21%
5Y Avg
76.94%
Market Cap
$8.55B
Gross Margin
51.87%
TTM Avg
52.87%
3Y Avg
53.77%
5Y Avg
54.60%
Market Cap
$9.97B
Gross Margin
90.45%
TTM Avg
90.21%
3Y Avg
89.67%
5Y Avg
89.38%
Market Cap
$10.37B
Gross Margin
17.13%
TTM Avg
18.71%
3Y Avg
19.98%
5Y Avg
20.79%
Market Cap
$10.41B
Gross Margin
13.07%
TTM Avg
12.36%
3Y Avg
12.43%
5Y Avg
12.55%
Market Cap
$10.80B
Gross Margin
31.86%
TTM Avg
31.70%
3Y Avg
34.15%
5Y Avg
35.17%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $7.51B | 62.72% | 67.35% | 56.65% | 54.08% |
| Oscar Health, Inc. (OSCR)vs › | $7.35B | 17.39% | 17.24% | 38.82% | 59.22% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.75B | 67.64% | 76.65% | 78.21% | 76.94% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.55B | 51.87% | 52.87% | 53.77% | 54.60% |
| Henry Schein, Inc. (HSIC)vs › | $9.64B | 29.69% | 29.43% | 29.32% | 29.12% |
| Universal Health Services, Inc. (UHS)vs › | $9.97B | 90.45% | 90.21% | 89.67% | 89.38% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 17.13% | 18.71% | 19.98% | 20.79% |
| Molina Healthcare, Inc. (MOH)vs › | $10.41B | 13.07% | 12.36% | 12.43% | 12.55% |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.80B | 31.86% | 31.70% | 34.15% | 35.17% |
| Bio-Techne Corporation (TECH)vs › | $11.21B | 64.96% | 65.60% | 66.84% | 66.79% |
Gross Margin
62.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 62.72% |
| 2025-12-31 | 89.74% |
| 2025-09-30 | 61.61% |
| 2025-06-30 | 61.99% |
| 2025-03-31 | 60.69% |
| 2024-12-31 | 60.83% |
| 2024-09-30 | 58.50% |
| 2024-06-30 | 45.50% |
| 2024-03-31 | 53.28% |
| 2023-12-31 | 55.20% |
| 2023-09-30 | 54.41% |
| 2023-06-30 | 54.11% |
| 2023-03-31 | 50.99% |
| 2022-12-31 | 48.18% |
| 2022-09-30 | 0.00% |
| 2021-12-31 | 49.56% |
| 2021-09-30 | 33.63% |
| 2021-06-30 | 22.46% |
| 2021-03-31 | 22.46% |
| 2020-12-31 | 26.78% |
| 2020-09-30 | 4.41% |
| 2020-06-30 | -1.45% |
| 2020-03-31 | -1.45% |
